Delivery Order SPE2DB25D3012-SPE2DB25FXADY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ticagrelor 90 mg tablets (60-count packages) with a ceiling value of $3,835.01. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive procurement. The order is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,487.91 to AmerisourceBergen Drug Corp for the supply of Ticagrelor 90 mg tablets (60-count packages) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $2,775.50 to AmerisourceBergen Drug Corp for 60 tablets of Ticagrelor 90 mg, a cardiovascular medication used to prevent blood clots. The non-set-aside, competitively awarded contract features firm fixed pricing and carries an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor serving military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,501.34 to AmerisourceBergen Drug Corp for the supply of Brilinta (ticagrelor) 90 mg tablets in a 60-tablet package. The contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under a larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.68 for 60 mg tablets of Brilinta (ticagrelor), an antiplatelet medication, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order issued under a non-competitive set-aside arrangement. The contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Brilinta 60 mg tablets (60-count packaging) with a ceiling value of $2,829.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationships with...
- The Defense Logistics Agency awarded a $1,664.52 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 60 mg on September 8, 2025, with completion scheduled for September 9, 2025. This contract is classified as firm fixed price with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,552.14 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packaging). This firm fixed-price, competitively awarded contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,188.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Brilinta 90 mg tablets (60-count units) valued at $3,168.70 under a firm fixed price contract. This delivery order was competitively awarded without set-aside designation and is set to be completed by August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXADYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,625.92 to AmerisourceBergen Drug Corp for the supply of Ticagrelor 90 mg tablets (60-count units) on September 17, 2025, with completion targeted for September 18, 2025. This competitively awarded, non-set-aside contract utilized firm fixed pricing and identified Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor within the federal medical procurement supply chain, particularly for military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract demonstrates AmerisourceBergen's established capability to fulfill federal medical supply requirements through competitive procurement processes and its role supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/17/25 |